Raaj Medisafe India Yönetim

Yönetim kriter kontrolleri 3/4

Raaj Medisafe India CEO'su Arpit Bangur, Aug2024 tarihinde atandı, in görev süresi bir yıldan az. şirketin hisselerinin 16.33% doğrudan sahiptir ve bu hisselerin değeri ₹ 185.10M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4.3 yıl ve 6.5 yıldır.

Anahtar bilgiler

Arpit Bangur

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	less than a year
CEO sahipliği	16.3%
Yönetim ortalama görev süresi	4.3yrs
Yönetim Kurulu ortalama görev süresi	6.5yrs

Son yönetim güncellemeleri

Recent updates

CEO

Arpit Bangur (37 yo)

less than a year

Görev süresi

₹8,000

Tazminat

Mr. Arpit Bangur has been Managing Director of Raaj Medisafe India Limited since August 14, 2024 and serves as its Chairman as well as its Director since May 13, 2013. He has completed B.E(Industrial and P...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Arpit Bangur	Managing Director & Chairman	less than a year	₹8.00k	16.33% ₹ 185.1m
Navin Jhawar	Joint MD & Executive Director	less than a year	₹1.68m	Veri yok
Ankita Jain	Chief Financial Officer	8.3yrs	₹502.69k	Veri yok
Sachin Sarda	Company Secretary & Compliance Officer	9.4yrs	₹324.00k	Veri yok

4.3yrs

Ortalama Görev Süresi

Deneyimli Yönetim: 524502 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.3 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Arpit Bangur	Managing Director & Chairman	11.5yrs	₹8.00k	16.33% ₹ 185.1m
Navin Jhawar	Joint MD & Executive Director	3.3yrs	₹1.68m	Veri yok
Vijendra Sood	Independent Director	13.2yrs	₹22.00k	Veri yok
Rajesh Gupta	Independent Director	13.2yrs	₹22.00k	Veri yok
Krishna Jajoo	Non-Executive Director	9.8yrs	₹3.00k	0.20% ₹ 2.3m
Rakesh Agrawal	Non-Executive Independent Director	2.3yrs	₹12.00k	Veri yok
Ateet Agrawal	Additional Non-Executive Independent Director	less than a year	Veri yok	Veri yok
Hemant Kasliwal	Additional Non-Executive Independent Director	less than a year	Veri yok	Veri yok

6.5yrs

Ortalama Görev Süresi

52yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 524502 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.5 yıldır).

Raaj Medisafe India Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Raaj Medisafe India Limited, Annual General Meeting, Sep 25, 2024

Raaj Medisafe India Limited, Annual General Meeting, Sep 27, 2023

Raaj Medisafe India Limited, Annual General Meeting, Sep 28, 2022

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Recent updates

New minor risk - Shareholder dilution

Second quarter 2025 earnings released: EPS: ₹0.49 (vs ₹0.97 in 2Q 2024)

Raaj Medisafe India Limited to Report Q2, 2025 Results on Nov 12, 2024

First quarter 2025 earnings released: EPS: ₹0.74 (vs ₹0.58 in 1Q 2024)

Raaj Medisafe India Limited, Annual General Meeting, Sep 25, 2024

Investor sentiment improves as stock rises 16%

Raaj Medisafe India Limited to Report Q4, 2024 Results on May 29, 2024

Raaj Medisafe India Limited to Report Q4, 2024 Results on Sep 29, 2024

Investor sentiment improves as stock rises 21%

Investor sentiment deteriorates as stock falls 19%

New minor risk - Share price stability

Investor sentiment improves as stock rises 18%

Third quarter 2024 earnings released: EPS: ₹0.86 (vs ₹1.00 in 3Q 2023)

Raaj Medisafe India Limited to Report Q3, 2024 Results on Feb 09, 2024

Investor sentiment improves as stock rises 16%

Raaj Medisafe India Limited to Report Q3, 2023 Results on Nov 08, 2023

New minor risk - Share price stability

New major risk - Financial position

Raaj Medisafe India Limited, Annual General Meeting, Sep 27, 2023

First quarter 2024 earnings released: EPS: ₹0.58 (vs ₹0.56 in 1Q 2023)

Raaj Medisafe India Limited to Report Q1, 2024 Results on Aug 08, 2023

Full year 2023 earnings released: EPS: ₹3.06 (vs ₹2.82 in FY 2022)

Investor sentiment deteriorates as stock falls 15%

Raaj Medisafe India Limited to Report Q4, 2023 Results on May 29, 2023

Investor sentiment improves as stock rises 16%

Third quarter 2023 earnings released: EPS: ₹1.00 (vs ₹1.03 in 3Q 2022)

Raaj Medisafe India Limited to Report Q3, 2023 Results on Feb 08, 2023

Investor sentiment improved over the past week

Raaj Medisafe India Limited to Report Q2, 2023 Results on Nov 11, 2022

Now 20% undervalued

Raaj Medisafe India Limited, Annual General Meeting, Sep 28, 2022

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Raaj Medisafe India Limited to Report Q1, 2023 Results on Aug 09, 2022

Less than half of directors are independent

Less than half of directors are independent

Raaj Medisafe India Limited Announces Demise of Narendra Bahadur Singh, Independent Non-Executive Director

Raaj Medisafe India Limited to Report Q4, 2022 Results on May 25, 2022

Raaj Medisafe India Limited to Report Q3, 2022 Results on Feb 14, 2022

Raaj Medisafe India Limited to Report Q3, 2021 Results on Feb 11, 2021

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş